abstract |
the compounds of the formula (i): the compounds of the formula (i) in which r1, het-1 and het-2 are as described in the specification and their salts and prodrugs, are glucokinase (glk) activators and are, thereby useful in the treatment of, for example, diabetes 2. processes for the preparation of compounds of formula (i) are also described. |